Pneumococcal pneumonia vaccine breakthroughs and failures after 13-valent pneumococcal conjugated vaccine: Table 1
| Autor: | Catarina Ferraz, Luísa Guedes Vaz, Joana Sobrinho-Simões, Teresa Nunes, Ana Filipe Almeida |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
0301 basic medicine
Serotype Pneumococcal disease business.industry 030106 microbiology Public Health Environmental and Occupational Health High effectiveness medicine.disease medicine.disease_cause Virology 03 medical and health sciences Pneumonia 0302 clinical medicine Conjugated vaccines Pneumococcal pneumonia Immunology Streptococcus pneumoniae medicine 030212 general & internal medicine business Vaccine failure |
| Zdroj: | The European Journal of Public Health. 26:887-889 |
| ISSN: | 1464-360X 1101-1262 |
| DOI: | 10.1093/eurpub/ckw089 |
| Popis: | The rate of invasive pneumococcal disease has markedly declined after the introduction of pneumococcal conjugated vaccines. In spite of the high effectiveness of this vaccine, there are some reports of vaccine failure and vaccine breakthroughs. Data on children with pneumococcal pneumonia in a European tertiary Hospital, from 2012 to 2014, were retrospectively collected before the implementation of pneumococcal conjugated vaccines in our country. We found four cases of pneumococcal serotype 3 vaccine failure and three cases of vaccine breakthroughs (two with serotype 3 and one with serotype 19A). All of these children were previously healthy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|